"Capecitabine 500mg"'

Capecitabine
CAPECITIME 500   is a chemotherapy medication used in the treatment of various types of cancer. It is classified as an antimetabolite, specifically a fluoropyrimidine. CAPECITIME 500   is converted into its active form within the body and interferes with the growth of cancer cells by disrupting their ability to replicate DNA and RNA.
Here are some key points about CAPECITIME 500  :
Mechanism of Action: CAPECITIME 500   is a prodrug that is enzymatically converted into its active form, fluorouracil (5-FU), within the body. Fluorouracil is a cytotoxic antimetabolite that disrupts the synthesis of DNA and RNA in rapidly dividing cancer cells.
Indications: CAPECITIME 500   is primarily used in the treatment of certain types of cancer, including breast cancer, colorectal cancer, and gastric (stomach) cancer. It is often used when other treatment options have been ineffective or are not suitable.
Dosage: The dosage of CAPECITIME 500   can vary based on the specific type of cancer being treated, the patient's individual response, and other factors. It is usually taken orally in the form of tablets.
Treatment Regimens: CAPECITIME 500   may be used as a single-agent chemotherapy or in combination with other chemotherapy drugs, depending on the type of cancer and the overall treatment plan.
Monitoring: Regular monitoring of blood counts, liver function tests, and other clinical assessments is important when using CAPECITIME 500  . This helps to ensure that the medication is well-tolerated and that any potential side effects are detected early.
Side Effects: Common side effects of CAPECITIME 500   can include nausea, vomiting, diarrhea, fatigue, hand-foot syndrome (palmar-plantar erythrodysesthesia), and mucositis (inflammation of the mucous membranes).
Precautions: CAPECITIME 500   should be used with caution in individuals with pre-existing medical conditions, particularly those affecting the liver and kidney function. Dose adjustments might be necessary based on renal function.
Interactions: CAPECITIME 500   can interact with other medications, so it's important to inform your doctor about any other medications or supplements you are taking.
Pregnancy and Lactation: CAPECITIME 500   is generally not recommended during pregnancy due to potential risks to the developing fetus. If you are pregnant or planning to become pregnant, discuss the risks and benefits with your healthcare provider.
Long-Term Use: The duration of CAPECITIME 500   treatment can vary based on the type of cancer and the patient's overall treatment plan. Some patients might need to use it for extended periods, especially for recurrent or advanced cancers.
For further information please contact:
info@sterispharma.com
Order now - https://www.sterisonline.com/product/capecitime-500-133655